Endeavor

Study Looks at Benefits of CAR T Over Standard of Care for Relapsed/Refractory Multiple Myeloma Patients

Analysis shows that cellular immunotherapy, cilta-cel, is usually less costly than standard of care treatment for relapsed/refractory multiple myeloma.

For This Doctor, It Really Is Brain Surgery

Neurosurgeon Dr. Arnold Etame hopes a new clinical trial will lead to better patient outcomes for those with brain cancer

Moffitt’s Magnolia Ball Raises Record $5.3 Million for Cancer Research

Flo Rida, Billy Dean and Moffitt’s house band, The ReMissions, entertained

New Breakthrough Therapy for Metastatic Melanoma Receives FDA Approval

The personalized therapy uses a patient’s own immune cells to recognize and fight cancer

Learn More About TIL Therapy

Dr. Patrick Hwu explains the process

What Does TIL Therapy Look Like?

The manufacturing process takes two to three months

Moffitt Expands TIL Therapy Research to Sarcoma Patients

Young sarcoma patients may benefit from tumor infiltrating lymphocyte therapy.

Moffitt at SouthShore on Track To Open in January 2025

Full service clinic will offer screenings, diagnostic imaging, blood draw, medical oncology, radiation therapy and infusion

How Can You Avoid Caregiver Burnout?

A cancer diagnosis can be overwhelming for both the patient and their loved ones